Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain
Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Ovarian Cancer | Ovaries | Spain Health